Panagora Asset Management Inc Trevena Inc Transaction History

Panagora Asset Management Inc

  • $20.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$1.53 - $3.13 $163 - $334
-107 Closed
0 $0
Q2 2020

Aug 12, 2020
SELL
$0.48 - $1.75 $3,000 - $10,939
-6,251 Reduced 98.32%
107 $0
Q3 2019

Nov 12, 2019
BUY
$0.81 - $1.06 $4,253 - $5,566
5,251 Added 474.35%
6,358 $6,000
Q2 2019

Aug 09, 2019
BUY
$0.94 - $1.6 $1,040 - $1,771
1,107 New
1,107 $1,000

About TREVENA INC

TRVN Quotes by TradingView
  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $313M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email